Clinical Trials Browser

Phase 1/2 × OGX-011 × Clear all

NCT00138658 2012-02-06

A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Completed

85 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung